Clinical Research
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Division of Pediatric Endocrinology and Diabetes at Stanford is actively involved in clinical research. The department has several on-going studies, as well as ones that are open for enrollment. If you are interested in being contacted about future studies, please sign the Patient List Research Consent Form. Once completed, please return it at your next clinic appointment or by mail to the following:
Bonita Baker
Division of Pediatric Endocrinology and Diabetes
Stanford University School of Medicine
Room G-313 Medical Center
300 Pasteur Drive
Stanford, CA, USA 94305-5208
Subject Recruitment
The following studies are currently recruiting study subjects. Please click on the study title for more information.
Study Title |
Looking for... |
Data Collection for Development of a Closed Loop Algorithm (DAD) |
Patients with type 1 diabetes who are using an insulin pump. |
| Development of Algorithms for a Prototype Closed Loop Insulin Pump (Closed Loop 1) | Patients with type 1 diabetes ages 3-31 who were diagnosed within the past year and are currently using an insulin pump. |
| Depot Lupron Study | Patients with newly diagnosed Central Precocious Puberty who have not started medical therapy. |
Efficacy of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes |
Patients with type 1 diabetes who are at least 8 years of age, have used insulin for at least one year, and are currently using an insulin pump or multiple daily injections of insulin. THIS STUDY IS FULLY ENROLLED |
| General Use of a Glucose Sensor | |
| Growth Hormone Therapy | Patients and families who are interested in growth hormone
therapy should be evaluated by a pediatric endocrinologist to determine
appropriateness of treatment. Risks and benefits of growth hormone therapy are reveiwed in the consent form. |
| Neuropsychological
and Neuroanatomical Studies in Young Children |
Patients with type 1 diabetes ages 3-10 who have been diagnosed with type 1 diabetes for at least 6 months. |
| Pediatric Intensive Care Unit Project | Patients hospitalized in the pediatric intensive care unit with hyperglycemia within the past 12 hours. |
| Pamidronate Therapy for Children | |
| Shared Studies | This is an IRB approved protocol to allow Stanford to do some tests required of OUTSIDE protocols here at Stanford when appropriate. |
| Skeletal risk factors in children and adolescents with Leukemia and Eating Disorders | Patients 9 to less than 21 years of age. Have had Anorexia
Nervosa or Eating Disorder Not Otherwise Specified diagnosed within
the past 5 years OR Have had Acute Lymphoblastic Leukemia and completed chemotherapy/radiation therapy at least 1 year ago. |
| Terbutaline Study | Patients with type 1 diabetes ages 12-17 diagnosed at least one year agowith a HbA1c below 8.0% |
| Type 1 Diabetes TrialNet: AntiCD20 Study | People with type 1 diabetes diagnosed within 3 months. NOW FULL - SEE CTLA-Ig |
| Type 1 Diabetes TrialNet: CTLA-4 Ig | People with type 1 diabetes diagnosed within 3 months and between ages 6 and 45. |
Relatives of people with type 1 diabetes. First degree blood relatives ages 1-45 and second degree relatives ages 1-20. |
|
| Type 1 Diabetes TrialNet: Oral Insulin Study | Relatives of people with type 1 diabetes. First degree blood relatives ages 3-45 and second degree relatives ages 3-20. |
| Type 1 Diabetes Genetics Consortium | We are looking for Mexican American and African American familties with one child with Type 1 diabetes and both parents (TRIOS). We are also looking for Mexican American and African American subjects with Type 1 Diabetes (CASES). Further, we are looking for Mexican American and African American subjects WITHOUT diabetes who have NO close relatives with diabetes (CONTROLS). |
Please check back for study updates and the addition of new studies.
